Or maybe it plays into the "reverse merger" thought with Rennova Health, which you briefly touched on earlier in the week upon the hiring of Thomas Mika as CFO. Rennova Health has until March 13, 2017 to fulfill the listing requirments to remain on the NASDAQ. (stay above $1.00US for 10 consecutive trading days)

(http://agoracom.com/ir/POETTechnologies/forums/discussion/topics/675561-new-cfo-thomas-mika-mba-harvard/messages/2115527#message)

The 'normal' waiting period is 6 months (4 months for TSE?).

By not having a waiting period, wouldn't the risk be somewhat reduced?

*NOTE*: I am not suggesting this will happen nor am I trying to pump anything - I am just providing some information for thought.